Silvant Capital Management LLC Invests $11.93 Million in Cencora, Inc. $COR

Silvant Capital Management LLC acquired a new position in Cencora, Inc. (NYSE:COR) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 42,144 shares of the company’s stock, valued at approximately $11,926,000.

Several other institutional investors have also added to or reduced their stakes in COR. Kemnay Advisory Services Inc. bought a new stake in shares of Cencora in the 4th quarter valued at $25,000. Oakworth Capital Inc. acquired a new stake in shares of Cencora in the 4th quarter valued at about $26,000. Elyxium Wealth LLC bought a new stake in shares of Cencora during the fourth quarter valued at approximately $27,000. Archer Investment Corp grew its position in Cencora by 134.3% in the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after purchasing an additional 47 shares during the period. Finally, Motiv8 Investments LLC acquired a new stake in Cencora in the 4th quarter valued at $29,000. 97.52% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on COR shares. Robert W. Baird set a $370.00 price objective on shares of Cencora in a report on Thursday, August 6th. Evercore restated an “outperform” rating and set a $350.00 price target on shares of Cencora in a report on Thursday, August 6th. Bank of America upped their price objective on Cencora from $280.00 to $285.00 and gave the company a “neutral” rating in a research note on Wednesday, June 24th. Weiss Ratings upgraded shares of Cencora from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, August 6th. Finally, Wells Fargo & Company boosted their price objective on Cencora from $331.00 to $395.00 and gave the company an “overweight” rating in a research note on Tuesday, August 11th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $370.85.

Cencora Stock Down 0.6%

Shares of NYSE:COR opened at $315.15 on Friday. The company has a market cap of $60.14 billion, a price-to-earnings ratio of 23.41, a PEG ratio of 1.82 and a beta of 0.57. Cencora, Inc. has a one year low of $244.82 and a one year high of $377.54. The firm has a fifty day moving average price of $301.86 and a two-hundred day moving average price of $311.85. The company has a debt-to-equity ratio of 3.53, a current ratio of 0.93 and a quick ratio of 0.58.

Cencora (NYSE:COR) last announced its earnings results on Wednesday, August 5th. The company reported $4.48 earnings per share for the quarter, topping analysts’ consensus estimates of $4.35 by $0.13. The business had revenue of $84.75 billion for the quarter, compared to analyst estimates of $84.31 billion. Cencora had a return on equity of 125.45% and a net margin of 0.79%.The company’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the prior year, the company earned $4.00 EPS. Analysts anticipate that Cencora, Inc. will post 17.87 EPS for the current fiscal year.

Cencora Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Friday, August 14th. Cencora’s dividend payout ratio is currently 17.83%.

Cencora declared that its board has approved a stock buyback program on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to buy up to 3.9% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s management believes its shares are undervalued.

Insider Buying and Selling at Cencora

In other news, Director Lauren M. Tyler acquired 550 shares of the firm’s stock in a transaction that occurred on Monday, June 22nd. The shares were bought at an average cost of $270.23 per share, with a total value of $148,626.50. Following the acquisition, the director owned 4,359 shares in the company, valued at approximately $1,177,932.57. This represents a 14.44% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.38% of the company’s stock.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.